375 related articles for article (PubMed ID: 30404544)
1. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
2. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
[No Abstract] [Full Text] [Related]
3. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
4. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
[TBL] [Abstract][Full Text] [Related]
5. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
Jordan M; Ghoreschi K; Eberle FC
Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
[TBL] [Abstract][Full Text] [Related]
6. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
[TBL] [Abstract][Full Text] [Related]
7. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
8. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
9. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
12. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
[TBL] [Abstract][Full Text] [Related]
13. The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Mordon S; Vignion-Dewalle AS; Abi-Rached H; Thecua E; Lecomte F; Vicentini C; Deleporte P; Béhal H; Kerob D; Hommel T; Duhamel A; Szeimies RM; Mortier L
Br J Dermatol; 2020 Jan; 182(1):76-84. PubMed ID: 31021404
[TBL] [Abstract][Full Text] [Related]
14. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
[TBL] [Abstract][Full Text] [Related]
15. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
16. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
[TBL] [Abstract][Full Text] [Related]
17. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
[TBL] [Abstract][Full Text] [Related]
18. Daylight photodynamic therapy: experience in the treatment of actinic keratosis in the San Gallicano Institute (Rome) and a review of literature.
Carbone A; Sperduti I; De Simone P; Piemonte P; Ferrari A; Buccini P; Silipo V; Iorio A; Frascione P; Eibenschutz L
G Ital Dermatol Venereol; 2020 Jun; 155(3):312-319. PubMed ID: 29368865
[TBL] [Abstract][Full Text] [Related]
19. Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
García-Gil MF; Gracia-Cazaña T; Cerro-Muñoz P; Bernal-Masferrer L; Navarro-Bielsa A; Gilaberte Y
Dermatol Ther; 2022 Nov; 35(11):e15879. PubMed ID: 36184916
[TBL] [Abstract][Full Text] [Related]
20. Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.
Mazzilli S; Garofalo V; Ventura A; Diluvio L; Milani M; Bianchi L; Campione E
Clin Cosmet Investig Dermatol; 2018; 11():485-490. PubMed ID: 30349346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]